Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tristan Gallenne
Observed names:
Gallenne, Tristan,
T. Gallenne
Institution:
Merus (Netherlands)
Observed institutions:
Inserm,
The Netherlands Cancer Institute,
Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers,
Merus (Netherlands),
Université de Nantes,
Nantes Université
show all 6
OpenAlex ID:
A5011313992
The First α Helix of Bax Plays a Necessary Role in Its Ligand-Induced Activation by the BH3-Only Proteins Bid and PUMA
2004
·
Pierre-François Cartron
, Tristan Gallenne
, et al.
·
Molecular Cell
·
316
PDF
Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis
2013
·
Christophe J. Desmet
, Tristan Gallenne
, et al.
·
Proceedings of the National Academy of Sciences
·
183
Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members
2009
·
Tristan Gallenne
, Fabien Gautier
, et al.
·
The Journal of Cell Biology
·
170
PDF
The Small Organic Compound HA14-1 Prevents Bcl-2 Interaction with Bax to Sensitize Malignant Glioma Cells to Induction of Cell Death
2006
·
Florence Manero
, Fabien Gautier
, et al.
·
Cancer Research
·
141
PDF
Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade
2018
·
Cecile A.W. Geuijen
, Camilla De Nardis
, et al.
·
Cancer Cell
·
119
PDF
Systematic functional perturbations uncover a prognostic genetic network driving human breast cancer
2017
·
Tristan Gallenne
, Kenneth N. Ross
, et al.
·
Oncotarget
·
44
PDF
Bax Activation by Engagement with, Then Release from, the BH3 Binding Site of Bcl-x L
2010
·
F. Gautier
, Y. Guillemin
, et al.
·
Molecular and Cellular Biology
·
43
Preclinical activity of MCLA-128, an ADCC enhanced bispecific IgG1 antibody targeting the HER2:HER3 heterodimer.
2014
·
Cecile Geuijen
, Eric Rovers
, et al.
·
Journal of Clinical Oncology
·
19
Abstract LB-261: Mechanism of action of MCLA-128, a humanized bispecific IgG1 antibody targeting the HER2:HER3 heterodimer
2015
·
Cecile Geuijen
, Eric Rovers
, et al.
·
Cancer Research
·
10
Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members
2009
·
Tristan Gallenne
, Fabien Gautier
, et al.
·
The Journal of Experimental Medicine
·
8
Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade
2021
·
Cecile A.W. Geuijen
, Camilla De Nardis
, et al.
·
Cancer Cell
·
6
PDF
Abstract 952: The bispecific antibody MCLA-129 impairs NSCLC tumor growth by targeting EGFR and c-MET, inhibiting ligand-induced signaling and promoting ADCC and ADCP
2021
·
David J. de Gorter
, Alexandre Deshiere
, et al.
·
Cancer Research
·
6
Abstract LB-C07: Preclinical evaluation of MCLA-129: A bispecific antibody targeting c-MET and EGFR
2019
·
Cecile Geuijen
, Mario di Matteo
, et al.
·
Molecular Cancer Therapeutics
·
4
Abstract 33: The binding mode of the bispecific anti-HER2xHER3 antibody MCLA-128 is responsible for its potent inhibition of HRG-driven tumorigenesis
2017
·
David Maussang-Detaille
, Camilla de Nardis
, et al.
·
Cancer Research
·
3
Abstract 957: Zenocutuzumab: An antibody that can overcome HER3 mediated HRG signalling in tumor cells by docking on HER2
2021
·
Cecile Geuijen
, David Maussang-Detaille
, et al.
·
Cancer Research
·
2
Correction: Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade
2021
·
Geuijen, Cecile A W
, De Nardis, Camilla
, et al.
·
Utrecht University Repository (Utrecht University)
La protéine à domaine BH3 PUMA (P53 Upregulated Modulator of Apoptosis) est un agoniste de Bax : implications dans la dépendance de cellules cancéreuses aux protéines anti-apoptotiques
2007
·
Tristan Gallenne
·
OpenGrey (Institut de l'Information Scientifique et Technique)
Show more works
View as search
Works count:
17
Citation count:
1,074
H-index:
9
I10-index:
9
Year
Topic
Type